https://oncomatryx.com/estos-cientificos-vascos-se-dedican-a-investigar-tumores-que-no-tienen-cura/ 2026-10-20T16:29:15+00:00 https://oncomatryx.com/en/estos-cientificos-vascos-se-dedican-a-investigar-tumores-que-no-tienen-cura/ 2026-10-20T18:29:15+02:00 https://oncomatryx.com/ensayo-clinico-omtx705/ 2026-10-16T06:59:46+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/clinical-trial-omtx705/ 2026-10-16T08:59:46+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-adquiere-una-empresa-austriaca-para-consolidar-sus-farmacos-contra-el-microentorno-tumoral/ 2026-10-16T06:59:45+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/uploads/2026/10/oncomatryx-adquisicion-2023-original.jpg https://oncomatryx.com/en/oncomatryx-acquires-an-austrian-company-to-consolidate-its-drugs-against-the-tumor-microenvironment/ 2026-10-16T08:59:45+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/uploads/2026/10/oncomatryx-adquisicion-2023-original.jpg https://oncomatryx.com/quimatryx-presenta-los-resultados-preclinicos-de-un-candidato-oral-contra-la-obesidad-que-reduce-el-peso-sin-perder-musculo-en-ratones/ 2026-10-09T10:26:01+00:00 https://oncomatryx.com/en/quimatryx-presents-preclinical-results-of-an-oral-candidate-against-obesity-that-reduces-weight-without-losing-muscle-in-mice/ 2026-10-09T12:26:01+02:00 https://oncomatryx.com/oncomatryx-convoca-a-su-consejo-asesor-cientifico-para-analizar-el-omtx705-y-su-cartera-de-adc-de-ultima-generacion/ 2026-10-06T11:02:58+00:00 https://oncomatryx.com/en/oncomatryx-calls-its-scientific-advisory-board-to-analyze-omtx705-and-its-portfolio-of-next-generation-add-ons/ 2026-10-06T13:02:58+02:00 https://oncomatryx.com/oncomatryx-gana-el-premio-a-la-mejor-presentacion-en-la-sesion-de-oncologia-de-biospain-2026/ 2026-10-02T09:39:03+00:00 https://oncomatryx.com/en/oncomatryx-wins-the-award-for-best-presentation-at-the-2026-biospain-oncology-session/ 2026-10-02T11:39:03+02:00 https://oncomatryx.com/oncomatryx-se-une-a-asebio-para-contribuir-al-ecosistema-biotecnologico-espanol/ 2026-09-25T09:29:27+00:00 https://oncomatryx.com/en/oncomatryx-joins-asebio-to-contribute-to-the-spanish-biotechnology-ecosystem/ 2026-09-25T11:29:27+02:00 https://oncomatryx.com/oncomatryx-participa-en-desafia-boston-el-programa-de-inmersion-de-icex-para-empresas-biotecnologicas-espanolas/ 2026-09-24T17:50:39+00:00 https://oncomatryx.com/en/oncomatryx-participates-in-the-boston-challenge-program-of-icex-for-spanish-biotechnology-companies/ 2026-09-24T19:50:39+02:00 https://oncomatryx.com/oncomatryx-co-authors-study-on-fap-targeted-bispecific-antibody-published-in-science-advances/ 2026-09-15T09:28:38+00:00 https://oncomatryx.com/en/oncomatryx-co-authors-study-on-fap-targeted-bispecific-antibody-published-in-science-advances/ 2026-09-15T11:28:38+02:00 https://oncomatryx.com/oncomatryxs-omtx705-selected-for-new-combination-research-collaboration-between-inxmed-and-hanchorbio/ 2026-07-27T13:53:07+00:00 https://oncomatryx.com/en/oncomatryxs-omtx705-selected-for-new-combination-research-collaboration-between-inxmed-and-hanchorbio/ 2026-07-27T15:53:07+02:00 https://oncomatryx.com/oncomatryx-recibe-el-reconocimiento-y-respaldo-de-la-ue-para-sus-pioneros-farmacos-contra-el-cancer-de-pancreas-y-otros-tumores-invasivos/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/en/oncomatryx-receives-the-recognition-and-support-of-the-eu-for-its-pioneering-drugs-against-pancreatic-cancer-and-other-invasive-tumors/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/oncomatryx-recauda-25-millones-de-euros-para-impulsar-los-ensayos-clinicos-de-omtx705/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/en/oncomatryx-raises-25-million-euros-to-boost-clinical-trials-of-omtx705/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/bio-2024-san-diego/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/bio-2024-san-diego/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/bioequity-donosti-spain-2024/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/bioequity-donosti-spain-2024/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-adquiere-tube-pharmaceuticals-gmbh-para-consolidar-su-innovadora-linea-de-adcs-dirigidos-al-microentorno-tumoral/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/en/oncomatryx-acquires-tube-pharmaceuticals-gmbh-to-consolidate-its-innovative-line-of-adcs-aimed-at-the-tumor-microenvironment/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/visita-lehendakari/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/en/visit-of-the-lehendakari/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/oncomatryx-anuncia-la-aprobacion-del-ind-por-parte-de-la-fda-y-la-aemps-para-omtx705-un-adc-pionero-dirigido-al-microentorno-tumoral-para-el-tratamiento-de-tumores-solidos-avanzados/ 2026-07-21T13:29:58+00:00 https://oncomatryx.com/en/oncomatryx-announces-the-approval-of-ind-by-the-fda-and-aemps-for-omtx705-a-pioneering-adc-aimed-at-the-tumor-microenvironment-for-the-treatment-of-advanced-solid-tumors/ 2026-07-21T15:29:58+02:00 https://oncomatryx.com/oncomatryx-recibe-de-manos-del-rey-el-premio-a-la-innovacion-del-banco-santander-y-la-camara-de-comercio-de-espana/ 2026-07-21T13:29:57+00:00 https://oncomatryx.com/en/oncomatryx-receives-the-innovation-award-from-the-king-of-the-bank-of-santander-and-the-chamber-of-commerce-of-spain/ 2026-07-21T15:29:57+02:00 https://oncomatryx.com/un-farmaco-espanol-da-una-nueva-esperanza-a-los-pacientes-con-cancer-metastasico/ 2026-07-21T13:29:57+00:00 https://oncomatryx.com/en/a-spanish-drug-gives-new-hope-to-patients-with-metastatic-cancer/ 2026-07-21T15:29:57+02:00 https://oncomatryx.com/eventos-2026/ 2026-07-21T13:29:57+00:00 https://oncomatryx.com/en/events-2026/ 2026-07-21T15:29:57+02:00 https://oncomatryx.com/kutxa-fundazioa-el-gobierno-vasco-y-el-gobierno-de-espana-impulsan-la-transformacion-de-oncomatryx-en-biofarmaceutica/ 2026-07-21T13:29:57+00:00 https://oncomatryx.com/en/the-kutxa-foundation-the-basque-government-and-the-spanish-government-are-promoting-the-transformation-of-oncomatryx-into-a-biopharmaceutical-product/ 2026-07-21T15:29:57+02:00 https://oncomatryx.com/oncomatryx-showcases-quantum-computing-powered-adc-platform-at-bio-international-convention-2026/ 2026-07-21T13:29:57+00:00 https://oncomatryx.com/en/oncomatryx-showcases-quantum-computing-powered-adc-platform-at-bio-international-convention-2026/ 2026-07-21T15:29:57+02:00 https://oncomatryx.com/oncomatryx-announces-a-e15-million-capital-increase-to-conduct-clinical-trials-against-the-tumor-micro-environment/ 2026-07-21T13:28:45+00:00 https://oncomatryx.com/en/oncomatryx-announces-a-capital-increase-of-15-million-euros-to-conduct-clinical-trials-against-the-tumor-micro-environment/ 2026-07-21T15:28:45+02:00 https://oncomatryx.com/declaro-la-guerra-al-estroma/ 2022-05-30T14:20:03+00:00 https://oncomatryx.com/en/i-declare-war-on-the-stroma/ 2022-05-30T16:20:03+02:00 https://oncomatryx.com/ampliacion-capital-oncomatryx-2022/ 2022-03-09T12:07:11+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/capital-increase-oncomatryx-2022/ 2022-03-09T13:07:11+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/premio-bizkaia-impacto-social/ 2022-03-07T12:16:42+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/bizkaia-social-impact-award/ 2022-03-07T13:16:42+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/pegs2020/ 2020-11-06T12:42:12+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/pegs2020/ 2020-11-06T13:42:12+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/nueva-cita-esmo-congress-2018/ 2018-10-03T15:52:52+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/new-date-for-esmo-congress-2018/ 2018-10-03T17:52:52+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-en-la-bio-europe-spring-2018/ 2018-02-01T13:57:42+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/oncomatryx-in-the-bio-europe-spring-2018/ 2018-02-01T14:57:42+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-en-la-bio-2017-san-diego/ 2017-04-28T04:40:08+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/oncomatryx-in-the-2017-san-diego-bio/ 2017-04-28T06:40:08+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/eventos-oncomatryx-en-marzo/ 2017-02-10T22:16:55+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/oncomatryx-events-in-march/ 2017-02-10T23:16:55+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/conjugados-anticuerpo-farmaco-fin/ 2016-11-12T11:01:12+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/conjugate-antibody-drug-fin/ 2016-11-12T12:01:12+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-en-bioeurope-2016/ 2016-09-19T07:24:46+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/oncomatryx-at-bioeurope-2016/ 2016-09-19T09:24:46+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/cancer-metabolism-and-the-tumour-microenvironment-conference-2/ 2016-08-03T11:00:53+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/cancer-metabolism-and-the-tumour-microenvironment-conference-2/ 2016-08-03T13:00:53+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/bio-san-francisco/ 2016-04-29T05:11:17+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/bio-san-francisco/ 2016-04-29T07:11:17+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/presentacion-aspic-poster/ 2016-04-22T11:16:00+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/presentacion-aspic-poster/ 2016-04-22T13:16:00+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-en-la-bio-europe-spring-2016/ 2016-02-20T11:21:39+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/oncomatryx-in-the-bio-europe-spring-2016/ 2016-02-20T12:21:39+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/ampliacion-de-capital-oncomatryx/ 2015-12-15T11:34:25+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/capital-increase-oncomatryx/ 2015-12-15T12:34:25+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/nueva-via-cancer-pancreas/ 2015-12-04T08:00:32+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/new-pancreatic-cancer-treatment-pathway/ 2015-12-04T09:00:32+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/adc-berlin-febrero/ 2015-07-31T00:13:23+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/adc-berlin-february/ 2015-07-31T02:13:23+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/el-tumor-microenvironment/ 2015-07-29T17:16:27+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/the-tumor-microenvironment/ 2015-07-29T19:16:27+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/oncomatryx-eitb/ 2015-05-20T10:23:01+00:00 https://oncomatryx.com/en/oncomatryx-eitb/ 2015-05-20T12:23:01+02:00 https://oncomatryx.com/uni-stuttgart-und-oncomatrix-starten-forschungskooperation/ 2015-05-20T09:54:06+00:00 https://oncomatryx.com/en/uni-stuttgart-and-oncomatrix-launch-research-collaboration/ 2015-05-20T11:54:06+02:00 https://oncomatryx.com/dmtxinvascan-testado-en-hospitales-de-eeuu/ 2013-06-26T14:38:30+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/dmtxinvascan-tested-in-hospitals-in-the-eu/ 2013-06-26T16:38:30+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/nuevos-tratamientos-contra-el-cancer-mas-invasivo/ 2013-01-01T15:31:45+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/new-treatments-for-the-most-invasive-cancers/ 2013-01-01T16:31:45+01:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/farmaceuticas-de-eeuu-contratan-a-un-laboratorio-vasco-para-investigar-el-cancer/ 2012-06-28T14:24:50+00:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg https://oncomatryx.com/en/european-pharmaceutical-companies-hire-a-basque-laboratory-to-investigate-cancer/ 2012-06-28T16:24:50+02:00 https://oncomatryx.com/wp-content/plugins/mr-oncomatryx-es/assets/historical-unavailable.svg